As focus shifts to oncology, BioNTech nabs Novartis exec as chief commercial officer
BioNTech has hired one of Novartis’ radioligand therapy leaders as its new chief commercial officer, as the company looks to pivot from reliance on its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
